Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma

Abstract. The MabThera and Involved field Radiotherapy study investigated efficacy and safety of involved field (IF) radiotherapy in combination with the anti-CD20 antibody Rituximab for early-stage follicular lymphoma (FL) in a prospective, single-arm multicenter phase 2 design. Eighty-five stage I...

Full description

Bibliographic Details
Main Authors: Klaus Herfarth, Peter Borchmann, Sven Schnaidt, Karin Hohloch, Volker Budach, Marianne Engelhard, Andreas Viardot, Rita Engenhart-Cabillic, Ulrich Keller, Gabriele Reinartz, Hans-Theodor Eich, Mathias Witzens-Harig, Clemens F. Hess, Bernd Dörken, Jan Dürig, Thomas Wiegel, Wolfgang Hiddemann, Eva Hoster, Christiane Pott, Martin Dreyling
Format: Article
Language:English
Published: Wolters Kluwer 2018-12-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000160

Internet

http://journals.lww.com/10.1097/HS9.0000000000000160

Similar Items